3 Given it is still in the early days regarding the success and second-order effects of these drugs, its difficult to determine if the impact on various areas of the stock market is short-lived
Studies have shown that many patients regain a significant portion of lost weight after discontinuing GLP-1 medications, highlighting the importance of sustainable lifestyle changes alongside pharmaceutical intervention
Novo Nordisk argued that the unusually long administrative delay at INPI warranted a compensatory patent term extension that would have pushed competitor market entry well past 2026
The compound's parent linear analog [Nle4,D-Phe7]--MSH (NDP--MSH) had been described nine years earlier by Sawyer, Sanfilippo, Hruby, and Hadley in PNAS 1980 [4]
Semaglutide is contraindicated for people with a personal or family history of certain types of thyroid cancer, or people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)